Companion website · Nature 2020
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Nature 581(7808):310–315 (2020) · doi:10.1038/s41586-020-2269-x
Quantitative microbiome profiling (QMP) matrices for the BMIS dataset [MetaCardis]: genus abundances and gut-specific metabolic modules (GMMs). Metadata available as Extended Data 1 of the article.
Data
Contents of bmis.zip, also available as individual files.
How to cite
If you use these data, please cite the original publication:
Vieira-Silva S, Falony G, Belda E, Nielsen T, Aron-Wisnewsky J, Chakaroun R, Forslund SK, Assmann K, Valles-Colomer M, Nguyen TTD, Proost S, Prifti E, others, MetaCardis Consortium, Clément K, Raes J. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581(7808):310–315 (2020). https://doi.org/10.1038/s41586-020-2269-x
@article{vieirasilva2020statin,
title = {{Statin therapy is associated with lower prevalence of gut microbiota dysbiosis}},
author = {Vieira-Silva, S. and Falony, G. and Belda, E. and Nielsen, T. and Aron-Wisnewsky, J. and Chakaroun, R. and Forslund, S. K. and Assmann, K. and Valles-Colomer, M. and Nguyen, T. T. D. and Proost, S. and Prifti, E. and others and {MetaCardis Consortium} and Clément, K. and Raes, J.},
journal = {Nature},
year = {2020},
volume = {581},
number = {7808},
pages = {310--315},
doi = {10.1038/s41586-020-2269-x}
}